BCL2 and B-cell non-Hodgkin lymphoma: The intrinsic pathway is tightly regulated by several members of the BCL-2 (B-cell Lymphoma) family, and it is established that CLL is frequently characterized by high expression levels of the antiapoptotic protein BCL-2 [22], where activation is correlated with the loss of miR-15a and miR-16-1, located on Chromosome 13q [23].